Company · IVZ
Invesco Ltd
Name as listed on its exchange; filed with the SEC as Invesco Ltd.
Nasdaq's symbol directory lists IVZ on the New York Stock Exchange as “Invesco Ltd Common Stock”.
In the 12 months to Nov 19, 2026: insiders sold on 5 occasions ($7.2M); 5 planned-sale notices; 1 filing by holders of 5% or more; 4 congressional trade disclosures; 9 company reports (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 41, No. 20
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Lo Andrew Tak Shing, Senior Managing Director sold $4.6M
- Butcher Stephanie, Senior Managing Director sold $1.5M
- DUKES LAURA ALLISON, Chief Financial Officer sold $1.0M
- WOOD PHOEBE A sold $97K
Every trade (5)
- SELLWOOD PHOEBE A sold $97K
- SELLLo Andrew Tak Shing, Senior Managing Director sold $3.2M
- SELLButcher Stephanie, Senior Managing Director sold $1.5M
- SELLLo Andrew Tak Shing, Senior Managing Director sold $1.4M
- SELLDUKES LAURA ALLISON, Chief Financial Officer sold $1.0M
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- WOOD PHOEBE A $97K
- Lo Andrew Tak Shing $3.2M
- Butcher Stephanie $1.5M
- Lo Andrew Tak Shing $1.4M
- DUKES LAURA ALLISON $1.0M
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Integrated Core Strategies (US) LLC 3.9%
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Kevin Hern (R-OK01): Sale $15,001 - $50,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
Executive branch · OGE Form 278-T
Reported by the President
1 confirmed trade on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports
- Sale: INVESCO LTD $100,001 – $250,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Regulation FD disclosure Nov 10, 2026
- Results of operations and financial condition Oct 27, 2026
- Entry into a material definitive agreement; Creation of a direct financial obligation Oct 27, 2026
- Regulation FD disclosure Oct 9, 2026
- Regulation FD disclosure Sep 10, 2026
- Departure or appointment of directors or officers; Regulation FD disclosure Aug 31, 2026
- Regulation FD disclosure Aug 11, 2026
- Results of operations and financial condition Jul 28, 2026
- Regulation FD disclosure Jul 10, 2026
Lobbying · Senate LDA reports
Lobbying filed
1 quarterly lobbying report for 2026 naming Invesco Ltd as the client: 1 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- MINDSET ADVOCACY, LLC $50K
Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.